4:07 PM ET
8-K
Executive Compensation
Larimar Therapeutics Executive Compensation
Larimar Therapeutics appointed John B. Harlow, Jr. as President and Chief Operating Officer, effective September 29, 2026. His compensation package includes an initial base salary of $560,000, a $35,000 signing bonus, and a target annual bonus of 40% of his base salary. The agreement also provides for severance benefits including nine months of base salary and COBRA coverage in the event of termination without cause.
- Counterparty
- John B. Harlow, Jr.